The Pollack Group (TPG) is proud to kick off 2026 as the newly appointed Agency of Record for Tower Cancer Research Foundation (TCRF), a nationally respected nonprofit advancing groundbreaking cancer research, supporting patients and families, and educating communities to improve cancer care across the United States.
Tower selected TPG for its ability to translate complex, mission-driven work into credible national visibility, unify scientific and human stories under a clear strategic narrative, and build long-term trust through earned media, thought leadership, and reputation stewardship. In an era when AI-driven search and discovery increasingly prioritize credibility, expertise, and third-party validation, this partnership reflects a shared commitment to ensuring Tower’s impact is recognized, trusted, and accurately represented across both human and machine audiences.
Founded in Southern California in 1996, Tower Cancer Research Foundation has made significant strides in the fight against cancer. The foundation has funded multiple critical scientific studies and clinical trials, enhancing our understanding of cancer progression and leading to the development of more effective treatments. Over nearly three decades, TCRF has evolved into a national organization that also educates healthcare professionals and the public to elevate standards of care.
“Many of us have been affected by cancer in one way or another, which makes this partnership deeply personal,” said Stefan Pollack, president of The Pollack Group. “Tower Cancer Research Foundation has had a meaningful impact on millions of lives, yet much of its extraordinary work remains underrecognized. In today’s environment, visibility alone isn’t enough; organizations must earn trust through consistent, credible storytelling. Our role is to ensure Tower’s leadership, research, and human impact are visible, trusted, and understood, so the right audiences know where progress, hope, and innovation are happening.”
As Agency of Record, TPG will serve as a strategic communications partner, helping Tower strengthen its national presence and reputation. The agency will lead brand and message development, earned media and public relations, and thought leadership initiatives designed to generate authoritative third-party coverage and expert commentary tied to clinical trials, research breakthroughs, partnerships, and key events. This approach will ensure Tower’s work is not only widely shared but indexed, reinforced, and validated across modern search and AI-driven platforms.
TPG will also support digital and social strategy, including organic and paid social media, GEO, SEO, and leadgen, donor communications, and website development, while leveraging strategic partnerships to expand Tower’s reach among priority audiences. Together, these efforts are structured to create a durable body of credible content that strengthens Tower’s long-term visibility, relevance, and trustworthiness in an evolving discovery landscape.
“This work matters to us on a human level,” Pollack added. “We’ve had colleagues, friends, and family members fight cancer. Being chosen to help advance research, elevate understanding, and ensure those affected know they are not alone is both an honor and a responsibility. We are committed to stewarding Tower’s mission with the care, rigor, and strategic focus it deserves.”
TPG’s integrated approach is designed to move beyond awareness alone, building credibility, deepening trust, and driving measurable engagement with the communities Tower serves. By aligning research excellence with compelling storytelling and third-party validation, the agency will help ensure Tower’s work is not only seen, but believed, valued, and supported.
